PO011 Modelling the cost-effectiveness of Deferasirox (Exjade) in the treatment of iron overloaded myelodysplastic syndrome patients von Karnon, J, Baladi, J.F

Volltext

7124 Association between time to disease progression (TDP) endpoints and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) von Delea, T, Khuu, A, Kay, A, Zheng, J, Baladi, J.F

Volltext

7131 Overall survival among metastatic renal cell carcinoma patients corrected for crossover using inverse probability of censoring weights: analyses from the everolimus phase III... von Wiederkehr, D, Howe, C.J, Casciano, R, Motzer, R, Zheng, J, Baladi, J.F

Volltext

7127 Results from additional analyses of patient reported outcomes in RECORD-1 – a randomized trial of everolimus with metastatic renal cell carcinoma patients von Beaumont, J, Cella, D, Hollaender, N, Zheng, J, Baladi, J.F, Hutson, T

Volltext

PCN11 The Challenges and Unmet Needs in the Management of Hepatocellular Carcinoma (HCC) Patients and Burden of Advanced HCC across Hong Kong, Singapore and Thailand von Yen, C., Ramaswamy, B., Baladi, J.F., Acorda, A., Xu, K., Gilliam, Y., Gowindah, R., Singh, S.S., Chen, Y.

Volltext

Ferritin Levels, Compliance and Adverse Events Related to Infused Iron Chelation Therapy in a Cohort of Patients from Usual Care Setting in the United States von Payne, K.A., Desrosiers, M.-P., Proskorovsky, I., Ishak, K., Lordan, N., Baladi, J.F.

Volltext

P-79 Transfusion and iron overload (IO)in MDS: Impact of infusion chelation therapy (ICT) on quality of life (QoL) and adherence von Abetz, L.N., Baladi, J.F., Jones, P.

Volltext

851 Cost-effectiveness of treatment with zoledronic acid (Zometa®) in prostate cancer patients von El ouagari, K., Baladi, J.F.

Volltext

Patient Satisfaction with Deferasirox (Exjade®, ICL670) an Oral Form of Chelation Therapy Versus Deferoxamine an Infused Chelation Therapy von Cappellini, M.D., Bejaoui, M., Agaoglu, L., Lai, M.E., Mangiagli, A., Strauss, G., Girot, R., Opitz, H., Abetz, L., Baladi, J.F., Ressayre-Djaffer, C., Ford, J.

Volltext

Satisfaction and Convenience of Chelation Therapy in Patients with Sickle Cell Disease (SCD): Comparison between Deferasirox (Exjade®, ICL670) and Deferoxamine (DFO) von Vichinsky, E., Fischer, R., Pakbaz, Z., Onyekwere, O., Porter, J., Swerdlow, P., Coates, T., Lane, P., Files, B., Mueller, B.U., Coïc, L., Forni, G., Abetz, L., Baladi, J.F., Ressayre-Djaffer, C., Gathmann, I., Alberti, D., Marks, P.

Volltext